- Home
- KTF vs IDYA Comparison
KTF vs IDYA Comparison
Compare KTF & IDYA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KTF
- IDYA
- Stock Information
- Founded
- KTF 1988
- IDYA 2015
- Country
- KTF United States
- IDYA United States
- Employees
- KTF N/A
- IDYA N/A
- Industry
- KTF Finance Companies
- IDYA Biotechnology: Pharmaceutical Preparations
- Sector
- KTF Finance
- IDYA Health Care
- Exchange
- KTF Nasdaq
- IDYA Nasdaq
- Market Cap
- KTF 349.0M
- IDYA 1.9B
- IPO Year
- KTF N/A
- IDYA 2019
- Fundamental
- Price
- KTF $8.85
- IDYA $22.10
- Analyst Decision
- KTF
- IDYA Strong Buy
- Analyst Count
- KTF 0
- IDYA 13
- Target Price
- KTF N/A
- IDYA $53.42
- AVG Volume (30 Days)
- KTF 103.3K
- IDYA 1.0M
- Earning Date
- KTF 01-01-0001
- IDYA 08-05-2025
- Dividend Yield
- KTF 3.54%
- IDYA N/A
- EPS Growth
- KTF N/A
- IDYA N/A
- EPS
- KTF 0.39
- IDYA N/A
- Revenue
- KTF N/A
- IDYA $7,000,000.00
- Revenue This Year
- KTF N/A
- IDYA $101.20
- Revenue Next Year
- KTF N/A
- IDYA $286.70
- P/E Ratio
- KTF $23.10
- IDYA N/A
- Revenue Growth
- KTF N/A
- IDYA N/A
- 52 Week Low
- KTF $7.40
- IDYA $13.45
- 52 Week High
- KTF $9.12
- IDYA $44.42
- Technical
- Relative Strength Index (RSI)
- KTF 48.39
- IDYA 58.41
- Support Level
- KTF $8.71
- IDYA $20.50
- Resistance Level
- KTF $8.93
- IDYA $22.86
- Average True Range (ATR)
- KTF 0.06
- IDYA 0.95
- MACD
- KTF 0.02
- IDYA -0.13
- Stochastic Oscillator
- KTF 63.64
- IDYA 67.71
About KTF DWS Municipal Income Trust
DWS Municipal Income Trust is a closed-ended fixed income mutual fund launched and managed by Deutsche Investment Management Americas, Inc. The company invests in the fixed income markets of the United States. The fund invests in investment-grade tax-exempt municipal securities which are exempt from federal income tax. The fund benchmarks the performance of its portfolio against the Barclays Municipal Bond Index. The Fund invests in various states, such as Texas, Florida, Pennsylvania, Illinois, and California.
About IDYA IDEAYA Biosciences Inc.
IDEAYA Biosciences Inc is an oncology-focused precision medicine company committed to the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. Its approach integrates small molecule drug discovery with extensive capabilities in identifying and validating translational biomarkers to develop targeted therapies for select patient populations that are likely to benefit from these targeted therapies. The company's clinical-stage product candidates include darovasertib (PKC), IDE397 (MAT2A), IDE849 (DLL3), IDE275/GSK959 (Werner Helicase), IDE161 (PARG), and IDE705/GSK101 (Pol Theta Helicase). In addition, it also working on other development candidates and has multiple earlier-stage preclinical programs.